Search results
Regeneron CEO Leonard Schleifer sells over $35 million in company stock By Investing.com
Investing.com· 6 days agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) has reported several transactions by its...
Leonard S. Schleifer Sells 25,000 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock
ETF DAILY NEWS· 5 days ago(NASDAQ:REGN – Get Free Report) CEO Leonard S. Schleifer sold 25,000 shares of Regeneron Pharmaceuticals stock in a transaction that occurred on Tuesday ...
With analysts seeing a likely US recession, here are 4 recession proof stocks to consider | Invezz
Invezz· 11 hours agoAt the beginning of 2024, Citigroup chief US economist predicted in a CNBC interview that the USA...
Examining the Potential Price Growth of Regeneron Pharmaceuticals, Inc.
Knox Daily· 7 days agoBernstein initiated its Regeneron Pharmaceuticals, Inc. [REGN] rating to an Outperform in a research note published on March 12, 2024; the price target ...
RBC maintains $1,185 target on Regeneron amid court case By Investing.com
Investing.com· 5 days agoOn Friday, RBC Capital maintained its Outperform rating on Regeneron (NASDAQ:REGN) Pharmaceuticals...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 1 day agoNEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. (“Regeneron” ...